| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/29/2004 | WO2004048402A3 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 07/29/2004 | WO2004046191A3 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 07/29/2004 | WO2004044156A3 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 07/29/2004 | WO2004042007A3 Somatic cell gene targeting vectors and methods of use thereof |
| 07/29/2004 | WO2004041304A3 Pain relief agents |
| 07/29/2004 | WO2004038026A3 Calcineurin-like human phosphoesterase |
| 07/29/2004 | WO2004038025A3 Genes and proteins for the biosynthesis of the glycopeptide antibiotic a40926 |
| 07/29/2004 | WO2004037988A3 Methods for synthesizing complementary dna |
| 07/29/2004 | WO2004037856A3 Plasmodium falciparum virulence factor var o |
| 07/29/2004 | WO2004033618A3 Stabilized naked dna compositions |
| 07/29/2004 | WO2004026892A3 Fragmentation of dna |
| 07/29/2004 | WO2004026285A3 Compositions and methods for treating heart disease |
| 07/29/2004 | WO2004021772A8 Immune cloning and uses thereof |
| 07/29/2004 | WO2004020631A3 Genetic suppression and replacement |
| 07/29/2004 | WO2004020627A3 Improved dna and proteins |
| 07/29/2004 | WO2004019879A8 Motilide compounds |
| 07/29/2004 | WO2004015088A3 Transposon-based transformation system |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2004011626A3 Assays and methods based on microcompetition with a foreign polynucleotide |
| 07/29/2004 | WO2004009761A3 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 07/29/2004 | WO2004007668A3 Improved transporters and their uses |
| 07/29/2004 | WO2003099853A3 Petide amidation process |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003095654A3 Method for producing a transgenic plant having modified transport of substances |
| 07/29/2004 | WO2003093313A3 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 07/29/2004 | WO2003083065A3 Improved methods for achieving expression from alphavirus vectors |
| 07/29/2004 | WO2003076596A3 Altering viral tropism |
| 07/29/2004 | WO2003070881A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/29/2004 | WO2003068915A3 Production of human antibodies in immunodeficient, non-human, mammalian hosts |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003054177A3 New glycosyl hydrolases |
| 07/29/2004 | WO2003044176A3 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| 07/29/2004 | WO2003040369A3 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| 07/29/2004 | WO2003034029A3 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
| 07/29/2004 | WO2003025172A3 Gene expression construct |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003022123A3 Methods of kidney transplantation utilizing developing nephric tissue |
| 07/29/2004 | WO2003018623A3 Papillomavirus proteins and pharmaceutical compositions |
| 07/29/2004 | WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 07/29/2004 | WO2002102979A8 Transformation of mono- and di- cotyledonous plants |
| 07/29/2004 | WO2002094994A3 Chimeric antigen-specific t cell-activating polypeptides |
| 07/29/2004 | US20040148667 by phenotypic analysis, genetic mapping and marking by means of transposons; for inducing an apomictic development in sexual plants (corn) |
| 07/29/2004 | US20040148666 Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof |
| 07/29/2004 | US20040148658 Phosphatase stress-related proteins and methods of use in plants |
| 07/29/2004 | US20040148657 Expression of recombinant human acetylcholinesterase in transgenic plants |
| 07/29/2004 | US20040148656 an efficient and inexpensive method for transient production of monoclonal antibodies by introduction of Agrobacterium bearing genes into already grown plant hosts |
| 07/29/2004 | US20040148655 of a brassinosteroids (BRs) biosynthetic locus, designated dwarfs (dwf5), each of which contain loss-of-function mutations in the sterol Delta 7 reductase gene; in vivo/vitro cultures |
| 07/29/2004 | US20040148654 for increasing yield in plants, particularly seed plants and protecting against environmental stress (drought, cold); genetic engineering |
| 07/29/2004 | US20040148653 Triacylglycerol lipases |
| 07/29/2004 | US20040148652 for producing stable dwarf crop plants with disease resistance; agriculture/horticulture; genetic engineering |
| 07/29/2004 | US20040148651 Maize glutamine synthetase gene promoter |
| 07/29/2004 | US20040148650 herbicide resistant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Eleusine indica; genetic engineering |
| 07/29/2004 | US20040148649 for plants cells, tissue or entire plants (maize, tobacco, alfalfa, rice, soybean, pea, wheat, barley, sunflower, potato, tomato, and cotton) which comprise a coding region for herbicide/insect/drought/cold resistance |
| 07/29/2004 | US20040148648 for improved methods of in vitro/vivo re-cloning to improve transgene expression and expression levels in transgenic animals and production of healthier transgenic cells and/or animal models |
| 07/29/2004 | US20040148647 comprising a gene which codes for a protein of interest, functionally linked to a hamster-ubiquitin/S27a-promoter and a gene which codes for a fluorescent protein; internal ribosomal entry site (IRES) |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040148644 Method for generating overexpression of alleles in genes of unknown function |
| 07/29/2004 | US20040147735 Deprotection of RNA |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147728 Method for increasing hydrophilicity of fluorescent label compounds |
| 07/29/2004 | US20040147727 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147723 Moringa seed proteins |
| 07/29/2004 | US20040147722 Novel secreted proteins |
| 07/29/2004 | US20040147721 Antigens and vectors for vaccination |
| 07/29/2004 | US20040147720 Novel guasonine triphosphate-binding protein -coupled receptor place 6002312, its gene and production and use of the same |
| 07/29/2004 | US20040147719 Type III bacterial strains for use in medicine |
| 07/29/2004 | US20040147718 Nucleotide and protein sequences of lats genes and methods based thereon |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147477 Antisense modulation of P70 S6 kinase expression |
| 07/29/2004 | US20040147476 For therapy and prophylaxis of virus infections, other pathogenic infections or cancers |
| 07/29/2004 | US20040147475 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| 07/29/2004 | US20040147474 For use as vaccines against bacterial infections, diagnosis, prophylactic and therapeutic uses. |
| 07/29/2004 | US20040147473 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147471 Antisense modulation of TNFR1 expression |
| 07/29/2004 | US20040147470 Nuclease resistance; for therapy and prophylaxis of disease |
| 07/29/2004 | US20040147469 Inhibiting the expression of primary proteoglycans; inhibiting the expression and/or activity of a chain initiation enzyme; inhibiting the expression and/or activity of a chain elongation enzyme |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147444 Use of a fusion protein comprising a latency associated peptide and a proteolytic cleavage site for providing latency to a pharmaceutically active agent |
| 07/29/2004 | US20040147437 Calycins |
| 07/29/2004 | US20040147435 Compositions and methods for importing biologically active molecules into cells and for treating inflammation |
| 07/29/2004 | US20040147432 Melanin-concentrating hormone analogs |
| 07/29/2004 | US20040147028 Yeast treatment |
| 07/29/2004 | US20040147027 comprises a double-stranded ribonucleic acid molecule, a cell-penetrating peptide, and a covalent bond linkage; for gene expression inhibition; for transfection, electroporation, liposomal delivery or microinjection; genetic engineering |
| 07/29/2004 | US20040147026 Lentivirus vector system |
| 07/29/2004 | US20040147025 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 07/29/2004 | US20040147011 High growth methanotrophic bacterial strain |
| 07/29/2004 | US20040147006 Amino acid sequences comprising nuclear localization signal petides for use as enzyme inhibitors in treatment of viral and nervous system disorders; gene therapy and mimetics |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146998 polyester synthesis-associated gene which functions and can be expressed with good efficiency in a yeast |
| 07/29/2004 | US20040146991 Identifying modulator of activation inducible lymphocyte immunomodulatory molecule (AILIM) for use in suppressing, preventing and/or treating inflammatory, autoimmune and allergic disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146989 Nucleotide sequences coding cytokine fusion protein for use in the prevention and treatment of tumor and viral infections |